// OVERVIEW
Pharma strategic investor participating in NewLimit's fundraise.
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·StrictlyVC·JUNE 3, 2026
“NewLimit raised $435M at a $3.1B valuation for anti-aging research, led by Founders Fund with participation from Kleiner Perkins, Thrive Capital, and notably Eli Lilly Ventures.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.